15 employees
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
1998
$40M
from 2 investors over 2 rounds
Northwest Biotherapeutics raised $40M on April 3, 2015
Investors: Woodford Investment Management
Northwest Biotherapeutics raised $35M on November 20, 2014